High purity Vesilute peptide cas3918-84-1 with good price
TDS 2 Inquiries
3918-84-1
Pharmaceutical Grade
99%
shanghai
COMINGS
1g,5g,10g,100g,1000g
2025-05-14
semaglutide,tirzepatide,Liraglutide,Retatrutide,5-amino-1MQ,SLU-PP-332
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionCertificatesBasic Info
-
Product Name:
L-α-Glutamyl-L-aspartic acid
Other Name:L-Aspartic acid,L-α-glutamyl-;Aspartic acid,N-L-α-glutamyl-,L-;L-Aspartic acid,N-L-α-glutamyl-;Aspartic acid,N-L-α-glutamyl-;L-α-Glutamyl-L-aspartic acid;L-Glutamyl-L-aspartic acid;α-L-Glutamyl-L-aspartic acid;NSC 186905;76: PN: WO2005016244 PAGE: 71 claimed protein;456: PN: WO2005081628 SEQID: 1565 claimed protein;4: PN: WO2008083678 PAGE: 33 claimed protein;170: PN: EP2161028 PAGE: 10 claimed protein;59: PN: WO2011146121 PAGE: 114 claimed sequence;10: PN: WO2013130683 TABLE: 7 claimed sequence;α-Glu-Asp;877605-44-2
CAS No.:3918-84-1
Molecular Formula:C9H14N2O7
InChIKeys:InChIKey=FYYSIASRLDJUNP-WHFBIAKZSA-N
Molecular Weight:262.22
Exact Mass:262.22
Categories:
Characteristics-
XLogP3:
-4.64
Melting Point:150-153 °C (decomp)
Hazard IdentificationClassification of the substance or mixture
no data available
GHS label elements, including precautionary statements
Pictogram(s) no data available Signal word no data available
Hazard statement(s) no data available
Precautionary statement(s) Prevention no data available
Response no data available
Storage no data available
Disposal no data available
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
semaglutide,tirzepatide,Liraglutide,Retatrutide,5-amino-1MQ,SLU-PP-332
-
Location:
No. 1, 19th Floor, Unit 2, Building 5, Southeast Residential Building (Hankou Yujiang Lanting), at the intersection of Hanshi Highway and Fufa South Road, Wuhu Street, Huangpi District, Wuhan City, Hu
-
Payment Terms:
TT against copy of documents,100% TT in advance
-
Average lead Time:
15
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
11-50
-
Year of Establishment:
2023
-
-
Inquiry History2 Inquiries
Country Product Purchase Quantity Date Posted 
United States
Vesilute
20 MG Apr 14, 2026
United States
Vesilute
10 MT Jan 8, 2026 Post an enquiry for this product
